Alimetry
Auckland, New Zealand· Est.
Non‑invasive gastric mapping platform delivering objective diagnostics for functional GI disorders.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Non‑invasive gastric mapping platform delivering objective diagnostics for functional GI disorders.
GastrointestinalFunctional GI Disorders
Technology Platform
Body Surface Gastric Mapping (BSGM) using a wearable adhesive electrode array combined with AI‑driven signal processing and symptom analytics to generate objective gastric electrophysiology reports.
Opportunities
Expansion into additional GI indications and broader payer reimbursement across the US, EU, and Asia can drive significant revenue growth.
Risk Factors
Regulatory and reimbursement hurdles, as well as competition from invasive motility tests and emerging capsule technologies, could limit market penetration.
Competitive Landscape
Alimetry differentiates itself with a non‑invasive, wearable BSGM platform, whereas competitors such as Medtronic rely on invasive manometry or capsule‑based diagnostics.